Idiopathic pulmonary fibrosis and GERD: links and risks

References

• Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. Longo DL, ed. N Engl J Med. 2018;378(19):1811–1823. doi:10.1056/NEJMra170575129742380
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. doi:10.1164/rccm.2009-040GL21471066
   PubMed Web of Science ®Google Scholar
• Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus CME. Am J Gastroenterol. 2006;101:1900–1920. doi:10.1111/j.1572-0241.2006.00630.x16928254
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol. 2013;27(3):325–337. doi:10.1016/j.bpg.2013.06.00823998972
   PubMed Web of Science ®Google Scholar
• de Bortoli N, Nacci A, Savarino E, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol. 2012;18(32):4363. doi:10.3748/wjg.v18.i32.436322969200
   PubMed Web of Science ®Google Scholar
• Boeckxstaens G, El-Serag HB, Smout AJPM, Kahrilas PJ. Symptomatic reflux disease: the present, the past and the future. Gut. 2014;63(7):1185–1193. doi:10.1136/gutjnl-2013-30639324607936
   PubMed Web of Science ®Google Scholar
• Roman S, Holloway R, Keller J, et al. Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry. Neurogastroenterology Motil. 2017;29(2):e12920. doi:10.1111/nmo.12920
   Web of Science ®Google Scholar
• Scarpellini E, Boecxstaens V, Broers C, Vos R, Pauwels A, Tack J. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms. Dis Esophagus. 2016;29(8):1054–1063. doi:10.1111/dote.1244326541138
   PubMed Web of Science ®Google Scholar
• Mello M, Gyawali CP. Esophageal manometry in gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(1):69–87. doi:10.1016/j.gtc.2013.11.00524503360
   PubMed Web of Science ®Google Scholar
• Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2013;21(6):1. doi:10.1097/MOO.0b013e3283658edf23262745
   PubMed Web of Science ®Google Scholar
• Tolone S, De Bortoli N, Marabotto E, et al. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterology Motil. 2015;27(10):1423–1431. doi:10.1111/nmo.12638
   PubMed Web of Science ®Google Scholar
• Tolone S, de Cassan C, de Bortoli N, et al. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD. Neurogastroenterology Motil. 2015;27(8):1175–1182. doi:10.1111/nmo.12606
   PubMed Web of Science ®Google Scholar
• Tolone S, Savarino E, Zaninotto G, et al. High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: a comparison with surgical in vivo evaluation. United Eur Gastroenterol J. 2018;6(7):981–989. doi:10.1177/2050640618769160
   PubMed Web of Science ®Google Scholar
• Ribolsi M, Savarino E, De Bortoli N, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40(8):966–973. doi:10.1111/apt.1291925109844
   PubMed Web of Science ®Google Scholar
• Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017;14(11):665–676. doi:10.1038/nrgastro.2017.13028951582
   PubMed Web of Science ®Google Scholar
• Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29(10):1–15. doi:10.1111/nmo.13067
   PubMed Web of Science ®Google Scholar
• Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–1362. doi:10.1136/gutjnl-2017-31472229437910
   PubMed Web of Science ®Google Scholar
• Zentilin P, Dulbecco P, Savarino E, Giannini E, Savarino V. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux. Dig Liver Dis. 2004;36(9):565–569. doi:10.1016/j.dld.2004.03.01915460839
   PubMedGoogle Scholar
• Savarino E, Zentilin P, Frazzoni M, et al. Characteristics of gastro-esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterology Motil. 2010;22(10):1061–e280. doi:10.1111/j.1365-2982.2010.01536.x
   PubMed Web of Science ®Google Scholar
• Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10(6):371–380. doi:10.1038/nrgastro.2013.5023528345
   PubMed Web of Science ®Google Scholar
• Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with Erosive Esophagitis and nonerosive reflux disease: study using combined impedance–pH off therapy. Am J Gastroenterol. 2010;105(5):1053–1061. doi:10.1038/ajg.2009.67019997095
   PubMed Web of Science ®Google Scholar
• Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103(11):2685–2693. doi:10.1111/j.1572-0241.2008.02119.x18775017
   PubMed Web of Science ®Google Scholar
• Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011;43(7):542–547. doi:10.1016/j.dld.2011.01.01621376679
   PubMedGoogle Scholar
• Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011;121(9):n/a-n/a. doi:10.1002/lary.21897
   Web of Science ®Google Scholar
• Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27(1):136–142. doi:10.1183/09031936.06.0003700516387946
   PubMed Web of Science ®Google Scholar
• Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113–1130. doi:10.1183/13993003.02316-201426424523
   PubMed Web of Science ®Google Scholar
• el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113(3):755–760. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9287965. Accessed December 15, 2018.9287965
   PubMed Web of Science ®Google Scholar
• Lee CM, Lee DH, Ahn BK, et al. Protective effect of proton pump inhibitor for survival in patients with gastroesophageal reflux disease and idiopathic pulmonary fibrosis. J Neurogastroenterol Motil. 2016;22(3):444–451. doi:10.5056/jnm1519226932897
   PubMed Web of Science ®Google Scholar
• Noth I, Zangan SM, Soares RV, et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2012;39(2):344–351. doi:10.1183/09031936.0009991021737563
   PubMed Web of Science ®Google Scholar
• Bédard Méthot D, Leblanc É, Lacasse Y. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest. 2018. doi:10.1016/j.chest.2018.07.038
   PubMed Web of Science ®Google Scholar
• Puglisi S, Torrisi SE, Vindigni V, et al. New perspectives on management of idiopathic pulmonary fibrosis. Ther Adv Chronic Dis. 2016;7(2):108–120. doi:10.1177/204062231562427626977280
   PubMed Web of Science ®Google Scholar
• Lee JS. The role of gastroesophageal reflux and microaspiration in idiopathic pulmonary fibrosis. Clin Pulm Med. 2014;21(2):81–85. http://www.ncbi.nlm.nih.gov/pubmed/24729673. Accessed, January 12, 2019.24729673
   PubMedGoogle Scholar
• Chen B, You WJ, Liu XQ, Xue S, Qin H, Jiang HD. Chronic microaspiration of bile acids induces lung fibrosis through multiple mechanisms in rats. Clin Sci. 2017;131(10):951–963. doi:10.1042/CS2016092628341659
   PubMed Web of Science ®Google Scholar
• Downing TE, Sporn TA, Bollinger RR, Davis RD, Parker W, Lin SS. Pulmonary histopathology in an experimental model of chronic aspiration is independent of acidity. Exp Biol Med. 2008;233(10):1202–1212. doi:10.3181/0801-RM-17.
   Web of Science ®Google Scholar
• Appel JZ, Lee SM, Hartwig MG, et al. Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir Res. 2007;8(1):87. doi:10.1186/1465-9921-8-8718042282
   PubMed Web of Science ®Google Scholar
• Wang Z, Bonella F, Li W, et al. Gastroesophageal reflux disease in idiopathic pulmonary fibrosis: uncertainties and controversies. Respiration. 2018;96(6):571–587. doi:10.1159/00049233630308515
   PubMed Web of Science ®Google Scholar
• Mise J, Lozo M, Mise K, et al. Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study. Med Sci Monit. 2014;20:255–261. doi:10.12659/MSM.88980024535066
   PubMed Web of Science ®Google Scholar
• Savarino E, Carbone R, Marabotto E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013;42(5):1322–1331. doi:10.1183/09031936.0010121223471347
   PubMed Web of Science ®Google Scholar
• Davis CS, Mendez BM, Flint DV, et al. Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation. J Surg Res. 2013;185(2):e101–e108. doi:10.1016/j.jss.2013.06.01123845868
   PubMed Web of Science ®Google Scholar
• Lee JS, Song JW, Wolters PJ, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J. 2012;39(2):352–358. doi:10.1183/09031936.0005091122183478
   PubMed Web of Science ®Google Scholar
• Ghebremariam YT, Cooke JP, Gerhart W, et al. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis. J Transl Med. 2015;13(1):249. doi:10.1186/s12967-015-0614-x26231702
   PubMed Web of Science ®Google Scholar
• Johannson KA, Strâmbu I, Ravaglia C, et al. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? Lancet Respir Med. 2017;5(7):591–598. doi:10.1016/S2213-2600(17)30219-928664861
   PubMed Web of Science ®Google Scholar
• Farrell S, McMaster C, Gibson D, Shields MD, McCallion WA. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux–related pulmonary aspiration. J Pediatr Surg. 2006;41(2):289–293. doi:10.1016/j.jpedsurg.2005.11.00216481237
   PubMed Web of Science ®Google Scholar
• Starosta V, Kitz R, Hartl D, Marcos V, Reinhardt D, Griese M. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease. Chest. 2007;132(5):1557–1564. doi:10.1378/chest.07-031617925430
   PubMed Web of Science ®Google Scholar
• Krishnan U, Mitchell JD, Messina I, Day AS, Bohane TD. Assay of tracheal pepsin as a marker of reflux aspiration. J Pediatr Gastroenterol Nutr. 2002;35(3):303–308. doi:10.1097/00005176-200209000-0001212352517
   PubMed Web of Science ®Google Scholar
• Lozo Vukovac E, Lozo M, Mise K, et al. Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study. Med Sci Monit. 2014;20:255–261. doi:10.12659/MSM.88980024535066
   PubMed Web of Science ®Google Scholar
• Hong SJ, Kim SW. Helicobacter pylori infection in gastroesophageal reflux disease in the Asian countries. Gastroenterol Res Pract. 2015;2015:985249. doi:10.1155/2015/98524925642246
   PubMed Web of Science ®Google Scholar
• Houghton LA, Lee AS, Badri H, DeVault KR, Smith JA. Respiratory disease and the oesophagus: reflux, reflexes and microaspiration. Nat Rev Gastroenterol Hepatol. 2016;13(8):445–460. doi:10.1038/nrgastro.2016.9127381074
   PubMed Web of Science ®Google Scholar
• Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184(12):1390–1394. doi:10.1164/rccm.201101-0138OC21700909
   PubMed Web of Science ®Google Scholar
• Allaix ME, Fisichella PM, Noth I, Herbella FA, Borraez Segura B, Patti MG. Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment. J Gastrointest Surg. 2014;18(1):100–105. doi:10.1007/s11605-013-2333-z24002768
   PubMed Web of Science ®Google Scholar
• Fahim A, Dettmar P, Morice A, et al. Gastroesophageal reflux and idiopathic pulmonary fibrosis: a prospective study. Medicina. 2011;47(4):28. doi:10.3390/medicina47040028
   Web of Science ®Google Scholar
• Gao F, Hobson AR, Shang ZM, et al. The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. BMC Gastroenterol. 2015;15:26. doi:10.1186/s12876-015-0253-y25881023
   PubMed Web of Science ®Google Scholar
• Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg. 2007;133(4):1078–1084. doi:10.1016/j.jtcvs.2006.09.08517382656
   PubMed Web of Science ®Google Scholar
• Ghebre YT, Raghu G. Idiopathic pulmonary fibrosis: novel concepts of proton pump inhibitors as antifibrotic drugs. Am J Respir Crit Care Med. 2016;193(12):1345–1352. doi:10.1164/rccm.201512-2316PP27110898
   PubMed Web of Science ®Google Scholar
• Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999;94(6):1464–1467. doi:10.1111/j.1572-0241.1999.1127_e.x10364008
   PubMed Web of Science ®Google Scholar
• Allaix ME, Rebecchi F, Morino M, Schlottmann F, Patti MG. Gastroesophageal reflux and idiopathic pulmonary fibrosis. World J Surg. 2017;41(7):1691–1697. doi:10.1007/s00268-017-3956-028258461
   PubMed Web of Science ®Google Scholar
• Hershcovici T, Jha LK, Johnson T, et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(11–12):1295–1305. doi:10.1111/j.1365-2036.2011.04870.x21999527
   PubMed Web of Science ®Google Scholar
• D’Ovidio F, Singer LG, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg. 2005;80(4):1254–1260. doi:10.1016/j.athoracsur.2005.03.10616181849
   PubMed Web of Science ®Google Scholar
• Hoppo T, Komatsu Y, Jobe BA. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance. Dis Esophagus. 2014;27(6):530–537. doi:10.1111/j.1442-2050.2012.01446.x23107023
   PubMed Web of Science ®Google Scholar
• Borges LF, Jagadeesan V, Goldberg H, et al. Abnormal bolus reflux is associated with poor pulmonary outcome in patients with idiopathic pulmonary fibrosis. J Neurogastroenterol Motil. 2018;24(3):395–402. doi:10.5056/jnm1802329969857
   PubMed Web of Science ®Google Scholar
• Gavini S, Finn RT, Lo W-K, et al. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients. Neurogastroenterology Motil. 2015;27(9):1326–1332. doi:10.1111/nmo.12627
   PubMed Web of Science ®Google Scholar
• Gavini S, Borges LF, Finn RT, et al. Lung disease severity in idiopathic pulmonary fibrosis is more strongly associated with impedance measures of bolus reflux than pH parameters of acid reflux alone. Neurogastroenterology Motil. 2017;29(5):e13001. doi:10.1111/nmo.13001
   Web of Science ®Google Scholar
• Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma. Am J Respir Crit Care Med. 2009;179(5):408–413. doi:10.1164/rccm.200808-1359OC19096004
   PubMed Web of Science ®Google Scholar
• Sweet MP, Herbella FAM, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244(4):491–497. doi:10.1097/01.sla.0000237757.49687.0316998357
   PubMed Web of Science ®Google Scholar
• Lo W-K, Goldberg HJ, Burakoff R, Feldman N, Chan WW. Increased proximal acid reflux is associated with early readmission following lung transplantation. Neurogastroenterology Motil. 2016;28(2):251–259. doi:10.1111/nmo.12720
   PubMed Web of Science ®Google Scholar
• Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–e19. doi:10.1164/rccm.201506-1063ST26177183
   PubMed Web of Science ®Google Scholar
• Raghu G, Yang ST-Y, Spada C, Hayes J, Pellegrini CA. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis. Chest. 2006;129(3):794–800. doi:10.1378/chest.129.3.79416537884
   PubMed Web of Science ®Google Scholar
• Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1(5):369–376. doi:10.1016/S2213-2600(13)70105-X24429201
   PubMed Web of Science ®Google Scholar
• Fidler L, Sitzer N, Shapera S, Shah PS. Treatment of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Chest. 2018;153(6):1405–1415. doi:10.1016/j.chest.2018.03.00829559309
   PubMed Web of Science ®Google Scholar
• Kreuter M, Wuyts W, Renzoni E, et al. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016;4(5):381–389. doi:10.1016/S2213-2600(16)00067-927050871
   PubMed Web of Science ®Google Scholar
• Costabel U, Behr J, Crestani B, et al. Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials. Respir Res. 2018;19(1):167. doi:10.1186/s12931-018-0866-030176872
   PubMed Web of Science ®Google Scholar
• Linden PA, Gilbert RJ, Yeap BY, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131(2):438–446. doi:10.1016/j.jtcvs.2005.10.01416434276
   PubMed Web of Science ®Google Scholar
• Raghu G, Mart D, Anstrom KJ, et al. Treatment of Idiopathic Pulmonary Fibrosis (IPF) with Laparoscopic Anti-Reflux Surgery (LARS) Is Associated With Improvement In Forced Vital Capacity (FVC). In: D94. Interstitial lung disease: innovative therapies and determinants of survival. American Thoracic Society International Conference Abstracts American Thoracic Society; 2013:A5711–A5711. doi:doi:10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5711
   Google Scholar
• Fisichella PM, Davis CS, Lundberg PW, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation. Surgery. 2011;150(4):598–606. doi:10.1016/j.surg.2011.07.05322000170
   PubMed Web of Science ®Google Scholar
• Cantu E III, Appel JZ III, Hartwig MG, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78:1142–1151. doi:10.1016/j.athoracsur.2004.04.04415464462
   PubMed Web of Science ®Google Scholar
• Patti MG, Vela MF, Odell DD, Richter JE, Fisichella PM, Vaezi MF. The intersection of GERD, aspiration, and lung transplantation. J Laparoendosc Adv Surg Tech A. 2016;26(7):501–505. doi:10.1089/lap.2016.017027218671
   PubMed Web of Science ®Google Scholar
• Raghu G, Pellegrini CA, Yow E, et al. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. Lancet Respir Med. 2018;6(9):707–714. doi:10.1016/S2213-2600(18)30301-130100404
   PubMed Web of Science ®Google Scholar
• Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Dig Liver Dis. 2016;48(8):851–859. doi:10.1016/j.dld.2016.05.01827321544
   PubMedGoogle Scholar
• Frazzoni L, Frazzoni M, de Bortoli N, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterology Motil. 2017;29(11):e13116. doi:10.1111/nmo.13116
   Web of Science ®Google Scholar
• Frazzoni M, de Bortoli N, Frazzoni L, et al. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol. 2017;52(4):444–451. doi:10.1007/s00535-016-1226-927241210
   PubMed Web of Science ®Google Scholar
• Frazzoni M, Savarino E, de Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14(1):40–46. doi:10.1016/j.cgh.2015.06.02626122764
   PubMed Web of Science ®Google Scholar
• de Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13(6):1082–1088.e1. doi:10.1016/j.cgh.2014.11.03525499991
   PubMed Web of Science ®Google Scholar
• Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, Savarino E. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn. Am J Gastroenterol. 2018;113(5):670–676. doi:10.1038/s41395-018-0044-529681623
   PubMed Web of Science ®Google Scholar
• Borges LF, Rangan V, Hathorn K, et al. 253 - Postreflux Swallow-Induced Peristaltic Wave (PSPW) index and Mean Nocturnal Baseline Impedance (MNBI) on impedance-ph testing predict lung function decline at 1 year in pulmonary fibrosis. Gastroenterology. 2018;154(6):S–61. doi:10.1016/S0016-5085(18)30660-7
   Web of Science ®Google Scholar
• Borges LF, Hathorn K, Gavini S, et al. Mean nocturnal baseline impedance on multichannel intraluminal impedance monitoring predicts one-year pulmonary function decline in patients with idiopathic pulmonary fibrosis. Gastroenterology. 2017;152(5):S131. doi:10.1016/S0016-5085(17)30771-0
   Web of Science ®Google Scholar
• Naik RD, Barrett C, Ferguson S, et al. Mucosal integrity testing can detect changes in esophageal and extraesophageal gerd. Gastroenterology. 2019;156(6):S-223-S-224. doi:10.1016/S0016-5085(19)37356-1
   Web of Science ®Google Scholar
• Hirano I, Pandolfino JE, Boeckxstaens GE. Functional lumen imaging probe for the management of esophageal disorders: expert review from the clinical practice updates committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017;15(3):325–334. doi:10.1016/j.cgh.2016.10.02228212976
   PubMed Web of Science ®Google Scholar